MarketWatch News on AMGN
1:24 PM todayNew
Moody's cuts Amgen rating to 'A3/Prime-2' from 'A2/Prime-1' - MarketWatch
4 minutes ago
Moody's cuts Amgen rating to 'A3/Prime-2' from 'A2/Prime-1' - MarketWatch
So far the stock has not reacted that negatively, and is hanging on to the bottom of the channel line. The converging bold blue lines indicate an incomplete Bullish pattern which could propel the stock to the recent highs. I would imagine Dykstra's buy point on this will be met so we can watch how he does.....

No comments:
Post a Comment